Caught in the crosshairs of Sen. Bernie Sanders, I-Vt., Catalyst Pharma has come up with a rationale for the $375,000 price tag on its rare disease therapy Firdapse—and it includes some well-worn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback